The healthcare company lifted its full-year guidance after a robust third quarter driven by Kabi and good organic growth at ...

In a report released today, Christian Ehmann from Warburg Research maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research ...

Morgan Stanley raised the firm’s price target on Fresenius SE (FSNUY) to EUR 41 from EUR 40 and keeps an Overweight rating on the shares.

Third Quarter 2024 Results Key Financial Results Revenue: €5.37b (up 3.5% from 3Q ...

But if you pick the right individual stocks, you could make more than that. To wit, the Fresenius SE & Co. KGaA (ETR:FRE) share price is 41% higher than it was a year ago, much better than the ...

The presentation was e-mailed to our distribution list earlier today and is available on fresenius.com. On Slide 2 of the presentation, you'll find the usual safe harbor statement. Unless stated ...

Deutsche Bank raised the firm’s price target on Fresenius SE (FSNUY) to EUR 44 from EUR 42 and keeps a Buy rating on the shares. The views and opinions expressed herein are the views and ...

Narrow-moat Fresenius SE turned in strong third-quarter results helped by rising medical utilization, and management increased its 2024 outlook ranges. To account for recent cash flow generated ...

Germany stocks were lower after the close on Wednesday, as losses in the Technology, Transportation & Logistics and Consumer ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Morgan Stanley raised the firm’s price target on Fresenius SE (FSNUY) to EUR 41 from EUR 40 and keeps an Overweight rating on the shares. TipRanks is the most comprehensive data set of sell side ...

Fresenius SE FRE0.24%increase; green up pointing triangle raised its full-year guidance after a strong third quarter driven by Kabi and good organic growth at Helios. The German healthcare company ...